A simple, cost-effective molecular assay may help manage growing spread of drug-resistant gonorrhea

October 26, 2020

Philadelphia, October 26, 2020 - A dual therapy treatment regimen of expanded-spectrum cephalosporins (ESCs) plus azithromycin (AZM) is the recommended standard of care for gonorrhea. A strain of the Neisseria (N.) gonorrhoeae that is resistant to the ESC and AZM combination has emerged around the world with the potential to make gonorrhea untreatable. The currently used screening methods for antimicrobial resistant (AMR) determinants are slow, expensive, and not widely available. In an article in The Journal of Molecular Diagnostics, published by Elsevier, researchers report a rapid and cheap method that can provide real-time surveillance to help control the spread of AMR strains of N. gonorrhoeae.

"N. gonorrhoeae has developed resistance to almost all classes of antibiotics that were previously recommended for treatment," explained lead investigator Junping Peng, MD, NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Key Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. "Timely determination and monitoring of AMR profiles are crucial for appropriately personalized treatment and maintenance of treatment effectiveness."

Current surveillance systems primarily depend on culture-based methods, which have high sensitivity but long turnaround times. Several nucleic acid amplification testing methods have been developed, but they are expensive and not widely available. Dr. Peng and his team have spent the past several years assessing the status of gonococcal AMR and the development of AMR screening technologies. They designed and developed a multiplex assay based on high-resolution melting (HRM) technology. Compared with other molecular methods that detect a single genetic mutation, HRM technology can detect the most frequent mutations associated with ESCs and AZM resistance in a single test. It uses a real time PCR system, equipment commonly found in most microbiological laboratories and clinical settings.

Forty-eight well-characterized N.gonorrhoeae clinical specimens and 15 non-gonococcal strains were selected for the initial assay establishment. The multiplex HRM assays were able to accurately identify different nucleotide variations of the AMR determinants related to ceftriaxone and azithromycin resistance. Then, results from 556 multiplex HRM tests of clinical isolates and samples were compared with results from whole gene sequencing and PCR sequencing of the same samples. Compared with whole genome sequencing, the sensitivity, specificity, positive predictive value, and negative predictive value of the multiplex HRM assays for detection of AMR determinants were 98.6 percent, 99.2 percent, 98.6 percent, and 99.2 precent, respectively. The results were available within 90 minutes at a cost of less than $1.00 per sample.

This sequencing-free HRM assay may be applied to large-scale epidemiological programs for increasing surveillance of ESCs and AZM resistance and supporting identification and investigation of antimicrobial-resistant N. gonorrhoeae outbreaks in real-time. By application of this assay, gonococcal AMR surveillance could be enhanced significantly, resulting in improved management programs aimed at controlling the further spread of antimicrobial-resistant N. gonorrhoeae strains and pathogen eradication.

"Our team has been committed to the assessment of the current status of gonococcal AMR and the development of AMR screening technologies to provide scientific and technological support for the effective prevention and treatment of gonorrhea," observed Dr. Peng. This fast, simple, and cheap method could have significant implications in resource-limited countries with a high burden of disease,"
-end-


Elsevier

Related Gonorrhea Articles from Brightsurf:

Physician advocates screening teen emergency room patients for sexually transmitted infections
Of the 20 million cases of sexually transmitted infections each year 10 million occur among adolescents and young adults.

A simple, cost-effective molecular assay may help manage growing spread of drug-resistant gonorrhea
A drug-resistant strain of the Neisseria (N.) gonorrhoeae has emerged around the world with the potential to make gonorrhea untreatable.

Test accurately IDs people whose gonorrhea can be cured with simple oral antibiotic
A test designed by UCLA researchers can pinpoint which people with gonorrhea will respond successfully to the inexpensive oral antibiotic ciprofloxacin, which had previously been sidelined over concerns the bacterium that causes the infection was becoming resistant to it.

Insight into mechanism of treatment-resistant gonorrhea sets stage for new antibiotics
Medical University of South Carolina researchers investigated the effects of mutations altering the structure of an essential protein in an antibiotic-resistant strain of Neisseria gonorrhoeae.

Shale drilling activity linked to increased sexually transmitted infections in Texas, Yale study
Researchers at the Yale School of Public Health have found that rates of two sexually transmitted infections (STIs), gonorrhea and chlamydia, are 15% and 10% higher, respectively, in Texas counties with high shale drilling activity (''fracking''), compared to counties without any fracking.

NIAID officials call for innovative research on sexually transmitted infections
Sexually transmitted infections, or STIs, pose a significant public health challenge.

Study: no link between 'extreme' personal grooming, STDs
Women who choose to shave or wax their pubic hair might not be raising their risk of sexually transmitted diseases (STDs) after all, according to a new study that found no connection between 'extreme' grooming and chlamydia or gonorrhea.

Researcher works to understand how gonorrhea develops resistance to antibiotics
As public health officials worry about the emergence of antibiotic-resistant gonorrhea, an MUSC researcher is tracing how antibiotics bind to a gonococcal protein, information that can help lead to new antimicrobials.

Researchers discover blocking key mineral uptake could prevent gonorrhea infection
Blocking the ability of the bacterial pathogen that causes gonorrhea to uptake the mineral zinc can stop infection by this widespread sexually transmitted infection, according to a study by the Institute for Biomedical Sciences at Georgia State University.

Study reports on bacterial STIs among men using PrEP
This study, which included nearly 3,000 mostly gay and bisexual men in Australia who received daily HIV preexposure prophylaxis (PrEP), reports on the association of bacterial sexually transmitted infections (STIs) by describing diagnoses of chlamydia, gonorrhea or syphilis among the men and behavioral risk factors.

Read More: Gonorrhea News and Gonorrhea Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.